Balancing Efficacy With Toxicity Among the Agents for HCC

Balancing Efficacy With Toxicity Among the Agents for HCC - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title Balancing Efficacy With Toxicity Among the Agents for HCC, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : Balancing Efficacy With Toxicity Among the Agents for HCC
link : Balancing Efficacy With Toxicity Among the Agents for HCC

Read also


Balancing Efficacy With Toxicity Among the Agents for HCC

Balancing Efficacy With Toxicity Among the Agents for HCC
Catherine Frenette, MD
Published Online:Nov 29, 2018

Catherine Frenette, MD: The 2 groups of lenvatinib [Lenvima] versus sorafenib [Nexavar] in the REFLECT trial were not stratified by AFP [alpha-fetoprotein] level. They were also not stratified by their underlying cause of liver disease. The patients in the lenvatinib group did have a slightly higher AFP than the patients in the sorafenib group. This may actually have resulted in a favorable imbalance in the positive for sorafenib. Additionally, hepatitis C patients were more frequent in the sorafenib group as compared with the lenvatinib group. This may have given a benefit to sorafenib. The reason for this discussion is that we recall, in the SHARP trial, when they broke out a subgroup of patients who were treated with sorafenib and had hepatitis C, had quite a longer median survival. In the SHARP trial, the overall survival [OS] in the subgroup was 10.7 months. In the hepatitis C–treated population with sorafenib, there may have been a longer OS than would have been seen in patients who were stratified for that risk factor.....


Transcript
Continue reading
https://www.targetedonc.com/case-based-peer-perspectives/hepatocellular-carcinoma/frenette-unresectable-hcc/balancing-efficacy-with-toxicity-among-the-agents-for-hcc


Thus articles Balancing Efficacy With Toxicity Among the Agents for HCC

that is all articles Balancing Efficacy With Toxicity Among the Agents for HCC This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article Balancing Efficacy With Toxicity Among the Agents for HCC the link address https://newsaninpiration.blogspot.com/2018/11/balancing-efficacy-with-toxicity-among.html

Subscribe to receive free email updates:

0 Response to "Balancing Efficacy With Toxicity Among the Agents for HCC"

Post a Comment